stallimycin has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, R | 1 |
| al-Said, NH | 1 |
| Sternbach, DL | 1 |
| Lown, JW | 2 |
| Marverti, G | 1 |
| Guaitoli, G | 1 |
| Ligabue, A | 1 |
| Frassineti, C | 1 |
| Monti, MG | 1 |
| Lombardi, P | 1 |
| Costi, MP | 1 |
| Sharma, SK | 1 |
| Morrissey, AT | 1 |
| Miller, GG | 1 |
| Gmeiner, WH | 1 |
3 other studies available for stallimycin and Cancer of Ovary
| Article | Year |
|---|---|
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; DNA, Neoplas | 1997 |
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells.
Topics: Antineoplastic Agents; Base Sequence; Cell Line, Tumor; Cisplatin; Distamycins; DNA Primers; Drug Re | 2012 |
Design, synthesis, and intracellular localization of a fluorescently labeled DNA binding polyamide related to the antibiotic distamycin.
Topics: Antiviral Agents; Biological Transport; Distamycins; DNA; Drug Design; Female; Fluorescence; Humans; | 2001 |